Search results for "vaccine."

showing 10 items of 789 documents

The association between respiratory tract infection incidence and localised meningitis epidemics: an analysis of high-resolution surveillance data fr…

2017

AbstractMeningococcal meningitis epidemics in the African meningitis belt consist of localised meningitis epidemics (LME) that reach attack proportions of 1% within a few weeks. A meningococcal serogroup A conjugate vaccine was introduced in meningitis belt countries from 2010 on, but LME due to other serogroups continue to occur. The mechanisms underlying LME are poorly understood, but an association with respiratory pathogens has been hypothesised. We analysed national routine surveillance data in high spatial resolution (health centre level) from 13 districts in Burkina Faso, 2004–2014. We defined LME as a weekly incidence rate of suspected meningitis ≥75 per 100,000 during ≥2 weeks; and…

Pediatricsmedicine.medical_specialty030231 tropical medicinelcsh:MedicineMeningococcal VaccinesMeningitis MeningococcalLogistic regressionArticleDisease Outbreaks03 medical and health sciences0302 clinical medicineRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesBurkina FasomedicineHumans030212 general & internal medicinelcsh:ScienceIntensive care medicineRespiratory Tract InfectionsMultidisciplinaryRespiratory tract infectionsbusiness.industryIncidenceIncidence (epidemiology)lcsh:ROutbreak[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieOdds ratiomedicine.disease3. Good health[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesmedicine.anatomical_structurePopulation Surveillancelcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSeasonsAfrican meningitis beltbusinessMeningitishuman activitiesRespiratory tract
researchProduct

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infa…

1996

Abstract OBJECTIVES: To assess the safety and tolerability of 12 lots of SmithKline Beecham Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTaP) in a large cohort of 22,000 vaccinees, with detailed analyses of reactivity, immunogenicity, and immune response to pertussis toxin in subsets. METHODS: In a prospective, double-blind, multicenter trial in Germany, 22,505 healthy infants received three vaccinations of DTaP at age 3, 4, and 5 months. Serious adverse events were followed for 1 month after each vaccination, and neurologic events for 1 year or longer. Serum IgG antibodies were assayed before vaccination and 1 month after vaccination. RESULTS: After 67,000 dos…

Pediatricsmedicine.medical_specialtyFeverFilamentous haemagglutinin adhesinDouble-Blind MethodSeizuresGermanyMedicineHumansProspective StudiesAdverse effectWhooping coughDiphtheria-Tetanus-Pertussis VaccineEpilepsybusiness.industryTetanusDiphtheriaIncidenceInfantSudden infant death syndromemedicine.diseaseVaccinationPediatrics Perinatology and Child HealthImmunologyPertactinbusinessSpasms InfantileSudden Infant DeathThe Journal of pediatrics
researchProduct

Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure

2007

Summary Vaccine effectiveness (VE) was determined with a case-cohort approach using Cox regression. Cases with confirmed systemic Hib infections in children born from 1 August 2000 to 31 December 2004 were ascertained through two independent nationwide active surveillance systems. A representative cohort of 1303 children born in the same time frame was randomly sampled in a nationwide immunisation survey. Thirty cases were eligible for VE calculation; 19 were unvaccinated and 11 vaccinated with hexavalent vaccines. VE was 68.4% (95% CI: 19.0–87.6) for incomplete primary series and 90.4% (95% CI: 70.6–96.8) for the full primary series. For full immunisation VE was 100.0% (95% CI: 52.7–100.0)…

Pediatricsmedicine.medical_specialtyHaemophilus influenzae typeDiseasemedicine.disease_causeHaemophilus influenzaeCohort StudiesTime frameGermanyHumansMedicineMeningitis HaemophilusHaemophilus VaccinesLicensureGeneral VeterinaryGeneral Immunology and Microbiologybiologybusiness.industryProportional hazards modelPasteurellaceaeHaemophilus influenzae type bPublic Health Environmental and Occupational HealthInfantbiology.organism_classificationInfectious DiseasesCase-Control StudiesChild PreschoolCohortImmunologyMolecular MedicinebusinessVaccine
researchProduct

Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Ita…

2020

The present study summarizes evidences of the impact that varicella vaccination (VV) introduction and coverage can have on varicella attributable hospitalization rates.A retrospective observational study was carried out by considering hospital discharge records and VV coverage at 24 months collected from 2003 to 2018 by the Italian Ministry of Health. All hospitalizations records reporting an ICD-9 CM 052.X code as the principal diagnosis or any of the five secondary diagnoses were considered as related to varicella. The hospitalization rate reduction was evaluated by calculating average annual percent change (AAPC) through joint-point analysis.Hospitalization rates showed a decreasing tren…

Pediatricsmedicine.medical_specialtyHerpesvirus 3 Human030231 tropical medicineVaricella vaccinationChickenpox Vaccine03 medical and health sciences0302 clinical medicineChickenpoxmedicineHospital dischargeHumans030212 general & internal medicineChildAgedGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic healthVaccinationPublic Health Environmental and Occupational HealthInfantRetrospective cohort studyAnnual Percent ChangeVaccinationHospitalizationInfectious DiseasesItalyMolecular MedicineChristian ministryPrincipal diagnosisbusinessVaricella vaccination.Vaccine
researchProduct

Precise reply and clarifications on behalf of Sicilian Public Health Authorities to the case report published by La Rosa and collegues

2016

The intussusception is one of the most frequent causes of occlusive syndrome in infants and in children.1 The mesenteric lymphadenopathy, wich is very rare post rotavirus vaccination, can cause intussusception,2-5 especially in genetically predisposed individuals.6 There is an association between intussusception and some classes of genotype.7-9 Two infants aged 3 months, vaccinated against rotavirus. After about a week, one of the 2 identical infants presented inconsolable crying, vomiting, loose stools mixed with blood, and was diagnosed with bowel obstruction with intussusception. He was operated in urgency. After a few hours, his brother presented vomiting, and was admitted to our Hospit…

Pediatricsmedicine.medical_specialtyImmunologyTwinsCase ReportPublic administrationRotavirus vaccinationSettore MED/42 - Igiene Generale E ApplicataRotavirus Infections03 medical and health sciencesHealth services0302 clinical medicine030225 pediatricsMedicineHumansImmunology and Allergy030212 general & internal medicineImmunization scheduleSicilyintussusceptionPharmacologybusiness.industryImmunization ProgramsPublic healthHealth PolicyRotavirus VaccinesInfantrotavirus vaccinationlanguage.human_languageClinical PracticeImmunization schedule; intussusception; pediatric population; rotavirus vaccination; Immunology and Allergy; Immunology; PharmacologylanguageMass vaccinationbusinessIdentical twinsSicilianpediatric populationPediatric population
researchProduct

Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions.

2014

In Italy, the introduction of Universal Varicella Vaccination (UVV) has been decided but postponed, as a national programme, until 2015, when data from Regions which have already implemented it will be available. Starting from 2003, eight Italian Regions (Basilicata, Calabria, Friuli Venezia Giulia, Apulia, Sardinia, Sicily, Tuscany and Veneto) have progressively introduced UVV, in their immunization programme, with different schedules in children aged 13-15 months and 5-6 years, currently a two-dose schedule is adopted by all Regions. In June 2013, an Interregional Group on Varicella Vaccination (IGVV) has been established in order to assess the effectiveness of varicella vaccination with …

Pediatricsmedicine.medical_specialtyImmunologyadverse events following varicella immunizationVaricellaSettore MED/42 - Igiene Generale E ApplicataEnvironmental healthmedicineImmunology and AllergyHealth policyChickenpox VaccinePharmacologyChickenpoxbusiness.industryIncidence (epidemiology)immunization coverageHealth services researchUniversal Varicella VaccinationnotificationsVaricella; Universal Varicella Vaccination; Notifications; Hospitalizations; Immunization coverage; Adverse effectsmedicine.diseaseVaccinationImmunizationVaccination coverageUniversal Varicella Vaccination; Varicella; adverse events following varicella immunization; hospitalizations; immunization coverage; notificationsbusinesshospitalization
researchProduct

Transient suppression of atopy in early childhood is associated with high vaccination coverage.

2003

Objective. To analyze prevalences of allergic sensitization and atopic disease in relation to vaccination coverage. Methods. A German atopy risk-enhanced birth cohort of 1314 neonates who were born in 1990 in 5 German cities was studied. A total of 943 children participated in the follow-up visit at 5 years of age. Atopic symptoms and diagnoses (derived from structured interviews), total serum immunoglobulin E, and specific immunoglobulin E against 9 common allergens (CAP Radio-Allergo-Sorbent Test Fluoro-Enzyme Immunoassay) were evaluated. Children were grouped into dose percentiles according to cumulative doses of any vaccine given up to 5 years of age (<10%, 0–11 doses; 10%–50%, 1…

Pediatricsmedicine.medical_specialtyPercentileDose-Response Relationship ImmunologicImmunoglobulin EDermatitis AtopicAtopyRadioallergosorbent TestHypersensitivityMedicineHumansEarly childhoodSensitizationAsthmaVaccinesbiologybusiness.industryImmunization ProgramsVaccinationInfant NewbornInfantAtopic dermatitisImmunoglobulin Emedicine.diseaseAsthmamedicine.anatomical_structureVaccination coverageChild PreschoolPediatrics Perinatology and Child Healthbiology.proteinbusinessFollow-Up StudiesPediatrics
researchProduct

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combi…

2006

Abstract Background To evaluate immunogenicity, reactogenicity, and safety of a hexavalent combination vaccine diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus- Haemophilus influenzae type b (DTPa-HBV-IPV/Hib) when coadministered with a 7-valent pneumococcal conjugate vaccine (PCV7). Methods Infants received either a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus- H. influenzae type b vaccine concomitantly with PCV7 or DTPa-HBV-IPV/Hib alone infants were vaccinated at 2, 3 and 4 months (primary immunization) and 12–15 months of age (booster dose). Local and systemic reactions and adverse events were monitored following each do…

Pediatricsmedicine.medical_specialtyPopulationBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinescomplex mixturesPneumococcal conjugate vaccinePneumococcal VaccinesmedicineHumansHepatitis B VaccinesVaccines CombinededucationWhooping coughBacterial CapsulesHaemophilus Vaccineseducation.field_of_studyReactogenicityGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryTetanusDiphtheriaPolysaccharides BacterialPublic Health Environmental and Occupational HealthInfantmedicine.diseaseVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesImmunologyAntibody FormationMolecular MedicineImmunizationbusinessmedicine.drugVaccine
researchProduct

The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion.

2013

Hajj is the annual pilgrimage to Mecca in the Kingdom of Saudi Arabia, and is one of the largest mass gathering events in the world. Acute respiratory tract infections are very common during Hajj, primarily as a result of close contact among pilgrims, intense congestion, shared accommodation and air pollution. A number of vaccines are (or have been) recommended for Hajj pilgrims in recent years. Several additional vaccines could significantly reduce the morbidity and mortality at Hajj and should be considered in health recommendations for pilgrims. Pneumococcal vaccines (particularly for those aged >65 years) are widely available, and have been shown to reduce the burden of disease associat…

Pediatricsmedicine.medical_specialtyPopulationSaudi ArabiaIslamPneumococcal conjugate vaccinePneumococcal InfectionsPneumococcal VaccinesEnvironmental healthMass gatheringMedicineTravel medicineHumanseducationeducation.field_of_studyTravelRespiratory tract infectionsbusiness.industryReligion and MedicinePublic Health Environmental and Occupational HealthPneumococcal polysaccharide vaccineVaccinationInfectious DiseasesCrowdingHajjbusinessTravel Medicinemedicine.drugTravel medicine and infectious disease
researchProduct

Qualitative analysis of determinants of measles, mumps, rubella vaccine uptake in European parents

2015

Background Parental concerns about measles, mumps and rubella (MMR) vaccination negatively influence decision to vaccinate their children, this leading to the recently reported vaccine coverage drop in Europe. The ESCULAPIO project, funded by the Italian National Centre for Disease Prevention and Control of the Ministry of Health (CCM), is investigating the main factors underlying decisions on vaccinations, in order to implement targeted campaigns and plan effective strategies. Methods A systematic literature review was carried out on studies describing the determinants underlying MMR vaccination uptake in European parents. Results A total of 45 studies were included in the analysis. The mo…

Pediatricsmedicine.medical_specialtyQualitative analysisMeasles-Mumps-Rubella Vaccinesystematic reviewbusiness.industryvaccine uptakemeasles mumps rubella; vaccine uptake; systematic reviewPublic Health Environmental and Occupational Healthmedicinebusinessmeasles mumps rubellaSettore MED/42 - Igiene Generale E Applicata
researchProduct